Erratum to: Inactivating hepatic follistatin alleviates hyperglycemia (Nature Medicine, (2018), 24, 7, (1058-1069), 10.1038/s41591-018-0048-0)

Rongya Tao, Caixia Wang, Oliver Stöhr, Wei Qiu, Yue Hu, Ji Miao, X. Charlie Dong, Sining Leng, Margaret Stefater, Nicholas Stylopoulos, Lin Lin, Kyle D. Copps, Morris F. White

Research output: Contribution to journalComment/debate

Abstract

In the version of this article originally published, the y axis labels in Fig. 4b,d were incorrect. In Fig. 4b, the unit on the label was (ng mg –1 ). This should have been (ng/ml). In Fig. 4d, the y axis label was Serum Fst (ng ml –1 ). It should have been Serum insulin (ng/ml). The errors have been corrected in the HTML and PDF versions of this article.

Original languageEnglish (US)
Number of pages1
JournalNature Medicine
Volume24
Issue number10
DOIs
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Erratum to: Inactivating hepatic follistatin alleviates hyperglycemia (Nature Medicine, (2018), 24, 7, (1058-1069), 10.1038/s41591-018-0048-0)'. Together they form a unique fingerprint.

  • Cite this

    Tao, R., Wang, C., Stöhr, O., Qiu, W., Hu, Y., Miao, J., Dong, X. C., Leng, S., Stefater, M., Stylopoulos, N., Lin, L., Copps, K. D., & White, M. F. (2018). Erratum to: Inactivating hepatic follistatin alleviates hyperglycemia (Nature Medicine, (2018), 24, 7, (1058-1069), 10.1038/s41591-018-0048-0). Nature Medicine, 24(10). https://doi.org/10.1038/s41591-018-0129-0